Literature DB >> 22875454

The barrier within: endothelial transport of hormones.

Cathryn M Kolka1, Richard N Bergman.   

Abstract

Hormones are involved in a plethora of processes including development and growth, metabolism, mood, and immune responses. These essential functions are dependent on the ability of the hormone to access its target tissue. In the case of endocrine hormones that are transported through the blood, this often means that the endothelium must be crossed. Many studies have shown that the concentrations of hormones and nutrients in blood can be very different from those surrounding the cells on the tissue side of the blood vessel endothelium, suggesting that transport across this barrier can be rate limiting for hormone action. This transport can be regulated by altering the surface area of the blood vessel available for diffusion through to the underlying tissue or by the permeability of the endothelium. Many hormones are known to directly or indirectly affect the endothelial barrier, thus affecting their own distribution to their target tissues. Dysfunction of the endothelial barrier is found in many diseases, particularly those associated with the metabolic syndrome. The interrelatedness of hormones may help to explain why the cluster of diseases in the metabolic syndrome occur together so frequently and suggests that treating the endothelium may ameliorate defects in more than one disease. Here, we review the structure and function of the endothelium, its contribution to the function of hormones, and its involvement in disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22875454      PMCID: PMC4423824          DOI: 10.1152/physiol.00012.2012

Source DB:  PubMed          Journal:  Physiology (Bethesda)        ISSN: 1548-9221


  103 in total

1.  Physiological hyperinsulinemia in dogs augments access of macromolecules to insulin-sensitive tissues.

Authors:  Martin Ellmerer; Stella P Kim; Marianthe Hamilton-Wessler; Katrin Hücking; Erlinda Kirkman; Richard N Bergman
Journal:  Diabetes       Date:  2004-11       Impact factor: 9.461

2.  The endothelial cell.

Authors: 
Journal:  Br Med J       Date:  1966-08-27

3.  Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance.

Authors:  M Laakso; S V Edelman; G Brechtel; A D Baron
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

4.  Arteriolar smooth muscle responses are modulated by an intramural diffusion barrier.

Authors:  M J Lew; R J Rivers; B R Duling
Journal:  Am J Physiol       Date:  1989-07

5.  Insulin infusion in conscious dogs. Effects on systemic and coronary hemodynamics, regional blood flows, and plasma catecholamines.

Authors:  C Liang; J U Doherty; R Faillace; K Maekawa; S Arnold; H Gavras; W B Hood
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

6.  Insulin resistance in type 2 (non-insulin-dependent) diabetic patients and their relatives is not associated with a defect in the expression of the insulin-responsive glucose transporter (GLUT-4) gene in human skeletal muscle.

Authors:  J Eriksson; L Koranyi; R Bourey; C Schalin-Jäntti; E Widén; M Mueckler; A M Permutt; L C Groop
Journal:  Diabetologia       Date:  1992-02       Impact factor: 10.122

7.  Glucose transport in human skeletal muscle cells in culture. Stimulation by insulin and metformin.

Authors:  V Sarabia; L Lam; E Burdett; L A Leiter; A Klip
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

8.  Abnormal capillary permeability and endothelial dysfunction in hypertension with comorbid Metabolic Syndrome.

Authors:  Giulia Dell'Omo; Giuseppe Penno; Laura Pucci; Mario Mariani; Stefano Del Prato; Roberto Pedrinelli
Journal:  Atherosclerosis       Date:  2004-02       Impact factor: 5.162

9.  Microvascular recruitment is an early insulin effect that regulates skeletal muscle glucose uptake in vivo.

Authors:  Michelle A Vincent; Lucy H Clerk; Jonathan R Lindner; Alexander L Klibanov; Michael G Clark; Stephen Rattigan; Eugene J Barrett
Journal:  Diabetes       Date:  2004-06       Impact factor: 9.461

10.  Receptor-mediated vectorial transcytosis of epidermal growth factor by Madin-Darby canine kidney cells.

Authors:  E Maratos-Flier; C Y Kao; E M Verdin; G L King
Journal:  J Cell Biol       Date:  1987-10       Impact factor: 10.539

View more
  26 in total

Review 1.  Hepatic Insulin Clearance: Mechanism and Physiology.

Authors:  Sonia M Najjar; Germán Perdomo
Journal:  Physiology (Bethesda)       Date:  2019-05-01

2.  Transendothelial movement of adiponectin is restricted by glucocorticoids.

Authors:  Thanh Q Dang; Nanyoung Yoon; Helen Chasiotis; Emily C Dunford; Qilong Feng; Pingnian He; Michael C Riddell; Scott P Kelly; Gary Sweeney
Journal:  J Endocrinol       Date:  2017-08       Impact factor: 4.286

Review 3.  Selective tissue targeting of synthetic nucleic acid drugs.

Authors:  Punit P Seth; Michael Tanowitz; C Frank Bennett
Journal:  J Clin Invest       Date:  2019-01-28       Impact factor: 14.808

4.  Lipid-induced insulin resistance does not impair insulin access to skeletal muscle.

Authors:  Cathryn M Kolka; Joyce M Richey; Ana Valeria B Castro; Josiane L Broussard; Viorica Ionut; Richard N Bergman
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-04-07       Impact factor: 4.310

5.  Caveolin-1 phosphorylation regulates vascular endothelial insulin uptake and is impaired by insulin resistance in rats.

Authors:  Hong Wang; Aileen X Wang; Kevin Aylor; Eugene J Barrett
Journal:  Diabetologia       Date:  2015-03-10       Impact factor: 10.122

6.  Insulin exits skeletal muscle capillaries by fluid-phase transport.

Authors:  Ian M Williams; Francisco A Valenzuela; Steven D Kahl; Doraiswami Ramkrishna; Adam R Mezo; Jamey D Young; K Sam Wells; David H Wasserman
Journal:  J Clin Invest       Date:  2018-01-08       Impact factor: 14.808

Review 7.  VEGF-targeted cancer therapeutics-paradoxical effects in endocrine organs.

Authors:  Yihai Cao
Journal:  Nat Rev Endocrinol       Date:  2014-07-22       Impact factor: 43.330

8.  Concomitant external pneumatic compression treatment with consecutive days of high intensity interval training reduces markers of proteolysis.

Authors:  Cody T Haun; Michael D Roberts; Matthew A Romero; Shelby C Osburn; James C Healy; Angelique N Moore; Christopher B Mobley; Paul A Roberson; Wesley C Kephart; Petey W Mumford; Michael D Goodlett; David D Pascoe; Jeffrey S Martin
Journal:  Eur J Appl Physiol       Date:  2017-10-26       Impact factor: 3.078

9.  Acute Nitric Oxide Synthase Inhibition Accelerates Transendothelial Insulin Efflux In Vivo.

Authors:  Ian M Williams; P Mason McClatchey; Deanna P Bracy; Francisco A Valenzuela; David H Wasserman
Journal:  Diabetes       Date:  2018-07-12       Impact factor: 9.461

Review 10.  The endothelium in diabetes: its role in insulin access and diabetic complications.

Authors:  Cathryn M Kolka; Richard N Bergman
Journal:  Rev Endocr Metab Disord       Date:  2013-03       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.